Agios Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €791.73M +66.8% €81.83M -151.0% 10.3% +0.44 pp N/A N/A
    (estimated) €474.59M +104.8% -€160.53M -40.3% -33.8% +0.82 pp N/A N/A
    (estimated) €231.76M +152.1% -€268.96M -28.7% -116.1% +2.9 pp -€205.06M -283.0% -88.5% -2.1 pp
    (estimated) €91.91M +143.4% -€377.31M +3.0% -410.5% +5.6 pp €112.04M -230.3% 121.9% +3.5 pp
    (estimated) €37.77M +21.3% -€366.37M -163.8% -970.0% -28 pp -€85.95M -74.0% -227.6% +8.4 pp
    €31.13M +36.1% €574.65M -291.4% 1,845.9% +32 pp -€331.08M +31.6% -1,063.5% +0.37 pp
    €22.88M +88.4% -€300.31M +372.3% -1,312.6% -7.9 pp -€251.67M -3.1% -1,100.0% +10 pp
    €12.15M +∞% -€63.59M -104.6% -523.6% -5.2 pp -€259.81M -24.2% -2,139.0% -21 pp
    €0.00 -100.0% €1.37B -578.7% N/A -€342.53M +45.6% N/A
    €173.32M +72.3% -€285.92M -15.5% -165.0% +1.7 pp -€235.29M -23.0% -135.8% +1.7 pp
    €100.57M +24.9% -€338.29M +14.6% -336.4% +0.30 pp -€305.74M +20.5% -304.0% +0.11 pp
    €80.51M +119.4% -€295.15M +10.0% -366.6% +3.6 pp -€253.70M +6.0% -315.1% +3.4 pp
    €36.69M -38.5% -€268.40M +58.5% -731.6% -4.5 pp -€239.34M -678.8% -652.4% -7.2 pp
    €59.61M +18.2% -€169.29M +68.6% -284.0% -0.85 pp €41.35M -185.4% 69.4% +1.7 pp
    €50.43M -9.5% -€100.42M +120.0% -199.1% -1.2 pp -€48.43M -0.6% -96.1% -0.086 pp
    €55.75M +155.8% -€45.64M +35.8% -81.9% +0.72 pp -€48.74M +3.7% -87.4% +1.3 pp
    €21.79M +1.8% -€33.61M +96.0% -154.2% -0.74 pp -€47.00M +14.6% -215.7% -0.24 pp
    €21.41M +15.0% -€17.15M -15.2% -80.1% +0.28 pp -€41.00M +261.1% -191.5% -1.3 pp
    €18.63M -€20.22M -108.6% -€11.36M -61.0%

    Notifications